ICAAC 2013
 
ICAAC 2013
September 9, 2013 — September 13, 2013
 
ICAAC, the premier conference on antimicrobial agents and infectious diseases, showcases the latest-breaking science and lectures from top researchers from around the world. With over 60% of its attendees living outside of the United States, ICAAC provides a rare opportunity to bring together the field’s foremost leaders to discuss the state of infection control and prevention on a global scale.
 
 
 
 
Available Packages
ASM Members
 
$349.00 
Student/Post-Doctoral Member
 
$239.00 
Non Member
 
$399.00 
Student/Post-Doctoral Non-Member
 
$299.00 
 
 
  •  
  •  
 
 
 
1 - 100 of 124
Order By 
Show 
Last Page
Page 
Next Page
001
Date:
Tuesday, Sep. 10, 2013
 
Time:
7:00 am –  9:00 am
 
Track:
Interactive ID Fellows Session
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom
 
This dynamic and popular session brings together ID professionals from ages 18-88 to discuss the latest summaries of the hottest trends in infectious disease. The session is highly interactive case-based and always a favorite. Upon completion of this Interactive ID Fellows Session the participant should be able to:
- Describe the important features of Hepatitis C diagnosis and management
- Recommend strategies for evaluating outbreaks associated with contaminated medicines
- Examine the current state of the globally important problem of Tuberculosis
- Recognize the need for antimicrobial stewardship programs.
$49.99 
 
 
002
Speaker:
 
Date:
Tuesday, Sep. 10, 2013
 
Time:
9:30 am – 10:30 am
 
Track:
Keynote Session
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom
 
The reductionist attitude of classic antibacterial therapy, crystallized in the dominant “culture of monotherapy” has contributed to perversely fix the old perception of “one disease-one pathogen-one drug”. Bacterial diseases are always the result of a complex array of pathogenic factors, and bacterial diseases are not only diseases of the individual, but complex diseases involving the groups and the environments. The renounce of recognizing the complex nature of bacterial diseases is a major threat for its control. Such complexity requires complex, multifaceted and integrated therapeutic interventions aiming to restore the health of all sick compartments involved in infection. Upon completion of this Keynote Session, the participant should be able to:
- Define the complexity of bacterial diseases and consider the need of novel approaches
- Discuss how bacterial diseases are not only diseases of the individual, but involve groups and environments
- Define the range of multifaceted therapeutic interventions that will be needed in the future.
$49.99 
 
 
003
Speaker:
 
Date:
Tuesday, Sep. 10, 2013
 
Time:
10:45 am – 11:45 am
 
Track:
ICAAC Lecture
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom
 
E. coli despite being among the organisms most commonly isolated in clinical microbiology laboratories remains poorly understood by many regarding its within-species phylogenetic diversity lineage-specific virulence and antimicrobial resistance capabilities host specificity (or lack thereof) and ecology. This session will describe the three broad pathotypes of E. coli (commensal diarrheagenic and extraintestinal pathogenic) focusing on the latter group i.e. ExPEC. Attendees will gain an appreciation of the implications of E. coli population structure for emerging antimicrobial-resistant and virulent E. coli clonal groups source tracking (including of foodborne resistant strains) rapid diagnostics and novel preventative measures. Upon completion of the ICAAC Lecture the participant should be able to:
- List the three broad pathotypes within E. coli and the different approaches that can be used to determine to which of these an E. coli isolate belongs
- Discuss the traditional relationship between virulence and antimicrobial resistance in E. coli and how and why this has changed over the past decade
- Explain how knowledge of transmission pathways and reservoirs for virulent and antimicrobial-resistant E. coli could be used for preventative purposes.
$49.99 
 
 
024
Date:
Tuesday, Sep. 10, 2013
 
Time:
2:30 pm –  4:30 pm
 
Track:
Literature Review
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom 3
 
This session will provide an overview of important manuscripts published within the past year. General topics that will be covered include, infectious diseases epidemiology, antibiotic resistance, emerging pathogens, pathogenesis, therapeutics, pediatric infections and vaccines, HIV, diagnostics, and transplantation. Upon completion of this Literature Review, the participant should be able to:
- Discuss the past year’s most noteworthy publications
- Restate recent advances in infectious diseases epidemiology, pathogenesis, diagnostics, and therapeutics
- Discuss and analyze recent advances relating to HIV infection.
$49.99 
 
 
025
Date:
Tuesday, Sep. 10, 2013
 
Time:
2:30 pm –  4:30 pm
 
Track:
Poster Summary Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Several short talks will be given describing work from selected posters presented in poster sessions at the conference. Antimicrobial compounds that are early in the drug development process (pre-Phase II) will be discussed. The intention is to highlight the next wave of compounds with the potential to move through the development pipeline. The audience is invited to later visit the posters for additional questions and informal discussions with the presenters. Upon completion of this Poster Summary Session the participant should be able to:
-Identify some key preclinical or early stage compounds in drug development that have not yet entered therapeutic (Phase 2) clinical trials
- Discuss selected new antimicrobial agents or new screening technologies that are being presented in Category F sessions during ICAAC
- Gain insights into the potential antibiotic pipeline for the near future.
$49.99 
 
 
026
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
To provide an interactive presentation of clinical cases and correlations with microbiology laboratory findings that demonstrates some of the pitfalls of microbial identification. This session will help the audience recognize some of these less appreciated clinical presentations of microorganisms and help them choose appropriate methods to arrive at the correct diagnosis and microbe identification. Upon completion of this Interactive Symposium Session the participant should be able to:
- Describe the advantages and limitations of certain conventional and contemporary diagnostic methods used for the identification of microbial pathogens
- Assess laboratory investigations in sick travelers returning from tropical regions
- Assess the laboratory approach to the diagnosis of infectious diseases.
$49.99 
 
 
027
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
The session outlined is designed to provide a high-quality evidence-based educational opportunity to advance the competence and understanding of attending physicians trainees and professionals. Through the review and discussion of interesting and relevant cases important information concerning practice performance and methodology is disseminated throughout the field. Upon completion of this Interactive Symposium Session the participant should be able to:
- Cite some of the latest significant literature of travelers medicine parasitology and tropical medicine
- Discuss the epidemiology of travelers illnesses and understand issues in management and prevention of these illnesses.
$49.99 
 
 
028
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
This session will provide an overview on the importance of multidrug-resistant (MDR) Klebsiella spp as a nosocomial pathogen. The first two lectures will highlight the resistance mechanisms reservoirs and changes in the molecular epidemiology of MDR Klebsiella spp. This will be followed by a description of which infection control measures are important for preventing the spread of Klebsiella spp as well as the treatment options available for infections due to these multipledrug-resistant bacteria. The session is important for all physicians and laboratory personal that are involved in health care aspects of patients infected with Klebsiella spp. Upon completion of this Symposium Session the participant should be able to:
- Examine the role of Klebsiella spp as an important nosocomial pathogen
- Recommend which treatment options are available for infections due to multidrug Klebsiella spp
- Recognize the changing epidemiology of multidrug Klebsiella spp.
- Describe which infection control measures are important for preventing the spread of Klebsiella spp.
$49.99 
 
 
029
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
301
 
Each panelist will present important advances in vaccines from the current literature and will discuss their potential impact. Panelists will solicit comments and questions from conveners other panelists and attendees. Hard copies of abstracts of the articles for discussion will be distributed to all attendees. Learners will be apprised of key developments in vaccine research and implementation as selected by leaders in this field of investigation. Upon completion of this Symposium Session the participant should be able to:
- Analyze the year's important advances and biomedical discoveries in vaccinology
- Assimilate the context of new scientific findings by discussion with experts in the field
- Assess the potential impact of discoveries on the prevention of infection
- Identify strategies to apply new advances to further discovery or clinical practice.
$49.99 
 
 
030
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
One of the hardest tasks in infection prevention is changing healthcare workers' behavior and practices. This session is designed to address these issues in general and also in the specific setting of the operating room. Two speakers will review the literature on the effect of discipline and communication in the operating room and surgical site infection rates. Two other speakers will discuss methods for helping healthcare workers adopt best practices as a means for preventing healthcare-associated infections. Upon completion of this Symposium Session the participant should be able to:
- Discuss the evidence that improving discipline in the operating room will help decrease surgical site infection rates
- Discuss the evidence that improving communication in the operating room will help decrease surgical site infection rates
- Describe principles from human factors engineering that could be used to improve practice
- Identify at least one way to modify a current infection prevention intervention in a way that increases healthcare worker adherence to best practices.
$49.99 
 
 
031
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
The cephalosporin antibiotics members of the beta-lactam class have been valuable drugs in the treatment of serious bacterial infections since they were first marketed 50 years ago. This symposium is intended to provide some historical context for their development and to convey that they remain valuable antibacterial agents to the present day. Clinical use will be discussed including the liabilities of misuse and overuse. The use of cephalosporins in combination with other agents particularly with beta-lactamase inhibitors will be described. Upon completion of this Symposium Session the participant should be able to:
- Discuss the history of the discovery and development of the cephalosporin beta-lactam antibiotics
- Examine newer members of this antibiotic class and the reasons for and advantages in their development
- Identify their clinical use in regard to their value in treating serious bacterial infections and concerns in regard to their misuse or overuse.
$49.99 
 
 
032
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
There is much interest in the role of nutrients and micronutrients in the support of host defense against infections. However there is controversy in the ability of supplements to help prevent or treat infections. This session sheds light on the intersection of human nutrition and infectious diseases. Key topics to be discussed include the use of vitamin D supplementation in viral and bacterial disease nutritional supplementation of HIV-infected persons and the application of zinc in special populations with infection. Upon completion of this Symposium Session the participant should be able to:
- Discuss the important relationship between nutritional status and infection risk/outcomes
- Recommend strategies for targeted use of nutritional supplements
- Examine the evidence for and against the use of vitamins and micronutrients in infectious disease management
- Recognize the patient populations most likely to benefit from nutritional supplementation.
$49.99 
 
 
033
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  6:45 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
This symposium will provide a detailed examination of a major fungal outbreak of disease related to contaminated steroids. It will provide an overview of the epidemiology of this tragic event. It will develop how treatment guidelines were constructed on a general basis but also dial down into what happened at the bedside. Finally it will provide insights into how this happened and how can it be prevented. Upon completion of this Symposium Session the participant should be able to:
- Discuss how this outbreak occurred and what was done
- Provide insights into how management must occur without strict guidelines
- Examine how the system deals with infectious disease emergencies.
$49.99 
 
 
034
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  7:15 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
405
 
Upon the completion of this Slide Session the participant should be able to:
- Describe recent developments in anti-infective PK/PD
- Examine the potential application of PK/PD for prevention of antimicrobial resistance
- PK/PD for anti-infective drug development and regulatory sciences.
$49.99 
 
 
035
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  7:15 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 3
 
Upon the completion of this Slide Session the participant should be able to:
- Recognize role of gene regulation in virulence
- Indicate key factors in bone and joint infections
- Discuss importance of adhesins and toxins in producing disease.
$49.99 
 
 
037
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  7:15 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
401
 
Upon the completion of this Slide Session the participant should be able to:
- Discover structural features of β-Lactamase proteins in substrate profiles
- Evaluate the β-Lactamase inhibitor interactions
- Discover new technologies and approaches used in structural studies.
$49.99 
 
 
038
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  7:15 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
503
 
Upon the completion of this Slide Session the participant should be able to:
- Describe the impact of Clostridium difficile (CAI) on healthcare resource utilization
- Describe the relationship between the use of proton pump inhibitors and CAI
- Describe efficacy of vancomycin for preventing recurrent CAI.
$49.99 
 
 
039
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  7:15 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Upon the completion of this Slide Session the participant should be able to:
- Evaluate RCT results for treatment of skin and soft tissue infection
- Evaluate RCT on treatment duration of vertebral osteomyelitis
- Evaluate RCT on treatment deration of pyelonephritis
- Evaluate RCT on treatment of chronic prostatitis.
$49.99 
 
 
040
Date:
Tuesday, Sep. 10, 2013
 
Time:
4:45 pm –  7:15 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
207
 
Upon the completion of this Slide Session the participant should be able to:
- Identify recent updates in treatment of CMV
- Discuss the impact of community acquired viral infections
- Recognize unique presentations of viral illnesses.
$49.99 
 
 
041
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Antimicrobial resistance is an urgent public health problem. New ways to prevent the emergence of drug resistance and treat it when present are required. This session will address the use of combination antimicrobial chemotherapy for the prevention and management of drug resistance for a range of microbial pathogens. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the evidence base for using TDM for the triazoles
- Identify the indications for TDM for the triazoles
- Formulate insight into implementing TDM in a hospital setting.
$49.99 
 
 
042
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
301
 
This session will provide an update on the emergence of multidrug-resistant (MDR) and extreme drug-resistant (XDR) gram-negative bacteria in the community setting. It will specifically address the role of human antibiotic use and human-to-human transmission in the prevalence of MDR and XDR gram-negative bacteria in the community setting. The session is important for all physicians and laboratory personal that are involved in health care aspects of patients infected with MDR and XDR gram-negative bacteria in the community setting. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Examine the role of MDR and XDR gram-negative bacteria as emerging causes of community-onset infections
- Describe the impact of human antibiotic use and human-to-human transmission in the prevalence of MDR and XDR gram-negative bacteria in the community setting
- Describe the emergence of multidrug-resistant (MDR) and extreme drug-resistant (XDR) gram-negative bacteria in the community setting
$49.99 
 
 
043
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
401
 
This session will focus on two important topics 1) the changing epidemiology of Neisseria gonorrhoeae including the utility of and rationale for testing non-genital sties and whether our current diagnostics are sufficient given the emergence of multidrug-resistant N. gonorrhoeae and 2) treatment options for multidrug-resistant N. gonorrhoeae. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review the rationale for testing non-urethral sites for gonorrhea
- Summarize the performance characteristics of diagnostic testing by the anatomic site of infection
- Describe how N. gonorrhoeae resistance trends determine selection of antimicrobial regimens
- Describe the current and future treatment options for N. gonorrhoeae.
$49.99 
 
 
044
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
112
 
Over recent years there has been considerable discussion about the increasing numbers of bacteria resistant to antibacterial agents that cause difficult to treat infections. There is also a dearth of new antibacterial drugs in development particular for infections caused by gram-negative bacteria. To address these issues several initiatives have been launched to encourage antibacterial drug discovery research and development. This session will discuss these initiatives and their advantages and disadvantages and the barriers that need to be overcome. In addition prior to use of any new antibacterial drugs agreement on how to use these new agents responsibly whilst ensuring equitable access in different healthcare systems and countries is required. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the status of initiatives to fund global consortia to discover
- Examine and develop new antibacterial drugs and the pros and cons of these initiatives
- Identify need to preserve new antibacterial drugs and so use them appropriately.
$49.99 
 
 
045
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
503
 
The speakers will present didactic sessions that describe novel ways that computers can be used to model risk of transmission of infectious diseases in hospitals and global settings. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss innovative methods for monitoring infection control practices in hospital settings
- Identify computer-based methods for monitoring infectious outbreaks and containment policies in global settings
- Examine how computer-based modeling can improve upon standard epidemiologic surveys of infectious diseases.
$49.99 
 
 
046
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
501
 
Two experts in stem cell transplantation and solid organ transplant will discuss diagnosis and treatment of common infections in these immunocompromised populations with special emphasis on viral fungal and respiratory pathogens. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the risks and timing of bacterial viral and fungal infections in stem cell and solid organ transplantation in children
- Identify viral and fungal infections and describe their treatment in the pediatric stem cell population
- Identify viral bacterial and fungal infections and describe their treatment in pediatric solid organ transplant patients.
$49.99 
 
 
047
Speaker:
 
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
205
 
The Centers for Disease Control and Prevention and the State of New York have published guidelines for evaluation of health-care providers who may have occupational exposure to potential blood-borne pathogens. These guidelines provide for the assessment of the liklihood of infection by the pathogen the provision of post exposure prophylaxis (PEP) to prevent HIV or Hepatitis B transmission and recommendations for follow-up evaluations. However questions remain on the validity of the guidance such as the timing of initiatio of PEP who should be offered PEP best drugs and duration of therapy. Experts will provide scientific rationale for PEP and review the new recommendations. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review scientific rationale for effectiveness of PEP
- Discuss the challenges of providing PEP in urgent situations
- Examine new therapeutic recommendations
- Discuss the timing dynamics from time of exposure to potential infection based on animal models.
$49.99 
 
 
048
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
This session will provide an overview on the challenges of healthcare-associated infections in countries with limited resources. It will address specifically the burden of endemic healthcare-associated infections in these countries and highlight possible preventive and surveillance strategies to be implemented in these settings.Upon completion of this Meet-the-Experts Session the participant should be able to:
- Measure the importance of infection prevention in countries with limited resources
- Discuss possible surveillance strategies to be implemented in countries with limited resources
- Identify the most frequent healthcare-associated infections in countries with limited resources
- Discuss the barriers to infection control in countries with limited resources.
$49.99 
 
 
049
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
113
 
Fusariosis and scedosporiosis are among the more frequent emerging invasive fungal infections. In both diseases treatment outcome depends on early targeted treatment. Experts and audience will discuss the measures to accomplish this goal. Steering targeted treatment prognosis is driven by timing of imaging studies to individualized dosing regimens. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the appropriate treatment in fusariosis and scedosporiosis
- Perform complete diagnostic work ups in these emerging fungal infections
- Measure treatment success
- Discuss how to avoid/recognize treatment failure early.
$49.99 
 
 
050
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
The session outlined is designed to provide a high-quality evidence-based educational opportunity to advance the competence and understanding of attending physicians trainees and professionals. Through the review and discussion of high caliber publications important information concerning practice performance and methodology is disseminated throughout the field. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Cite recent examples of advances in travel and tropical medicine which can be incorporated into their practice and research.
$49.99 
 
 
051
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
203
 
This meet-the-expert session will focus on issues related to donor derived infections after solid organ transplantation. Hallmarks of donor derived infections will be reviewed. The importance of early recognition with communication of potential infections to health care providers who are caring for the other recipients of a common donor will be discussed. Additionally global reporting systems for donor derived infections will be discussed; the U.S. and French reporting systems will be compared and contrasted. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Recognize key features of post transplant infections that are associated with donor derivation
- Recognize the importance of reporting these infections and how early recognition can impact post transplant outcomes
- Discuss the role of centralized reporting systems for donor derived infections and how the impact of these systems on transplant outcomes.
$49.99 
 
 
051a
Date:
Wednesday, Sep. 11, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
505
 
Healthcare-associated infection surveillance methodology is rapidly evolving given changes in the electronic health record and increased interest in public reporting of healthcare-associated infection (HAI) rates. Traditional surveillance methodology has relied on clinical judgment as a key component of HAI definitions but recent data suggests that issues of inter-rater reliability may make interpretation difficult when comparing rates among institutions and that the use of simple objective and potentially automatable surveillance definitions may be more effective at determining the rank of facilities according to their true underlying infection rates. The speakers will present the rationale and data supporting two new surveillance definitions for central line associated bloodstream infections (CLABSI) and adverse events associated with mechanical ventilation. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review the advantages and disadvantages of simple objective HAI surveillance definitions
- Identify a proposed novel CLABSI surveillance definition
- Examine a proposed novel surveillance definition for ventilator-associated adverse events.
$49.99 
 
 
052
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
Hospital-acquired influenza is associated with significant morbidity and mortality in hospitalized patients. This interactive session provides a debate on nosocomial influenza its transmission routes and effective prevention and control measures. Upon completion of this Interactive Symposium Session the participant should be able to:
- Identify the most effective measures for the prevention and control of nosocomial influenza
- Discuss controversies arising from transmission models
- Describe the components of successful prevention campaigns.
$49.99 
 
 
053
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
This interactive symposium will address current challenges in transplantation. This will include preventive strategies related to donor selection in solid organ transplantation and the use of live virus vaccines following transplantation. Difficult to treat viral infections will be considered. Guidelines for safe living after transplantation will be reviewed. Upon completion of this Interactive Symposium Session the participant should be able to:
- Recognize the impact of donor selection on the outcome of solid organ transplant recipients
- Discuss how to recognize and manage adenovirus infections in stem cell transplant recipients
- Evaluate prophylactic measures for transplant recipients including vaccination and strategies for safe living.
$49.99 
 
 
054
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Antimicrobial resistance is an urgent public health problem. New ways to prevent the emergence of drug resistance and treat it when present are required. This symposium will address the use of combination antimicrobial chemotherapy for the prevention and management of drug resistance for a range of microbial pathogens. Upon completion of this Symposium Session the participant should be able to:
- Examine the PK/PD principles for treating pneumonia
- Identify the role of measuring drug concentrations within the lung
- Discuss the use of preclinical models of pneumonia for predicting the clinical response to antimicrobial agents.
$49.99 
 
 
055
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
Since the discovery of sulfonamides the goal of anti-infective therapy has been to kill the pathogen. However recent science indicates that the host response to the pathogen profoundly influences the clinical course and outcome of infections. Killing the pathogen drives resistance and may not be necessary to treat infections. This symposium will review cutting edge approaches to find new ways to treat infections modulate host response to the pathogen and find new ways to screen for lead anti-infective compounds. Upon completion of this Symposium Session the participant should be able to:
- Examine the definitions of and data regarding static vs. cidal anti-infective strategies
- Discuss the potential for host modulation to alter the course of infection without attacking pathogens
- Describe cutting edge approaches to identify new therapies for infections.
$49.99 
 
 
056
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
The session aims to provide an overview about the overall knowledge in relation with the resistome meaning the resistance genes as a whole. After an introduction aiming to define what is a resistome and which are the tools to investigate it two lectures will present in detail the current data on the animal and on the environmental resistomes respectively. In addition there will be a focus on the characteristics of plasmids bearing resistance genes and their potential role in dissemination the resistance traits from ecological sites to other ones. Upon completion of this Symposium Session the participant should be able to:
- Discuss what is defining a resistome and what can we expect from its characterization
- Analyze the relationships between human animal and environmental resistance sources
- Discuss updates about the current knowledge on resistance traits in animals
- Examine what can provide fundamental investigations to the clinical microbiology.
$49.99 
 
 
057
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
401
 
This session will provide an overview on the latest developments regarding C. difficile. The first two lectures will highlight the differences in antimicrobial resistance and molecular epidemiology of C. difficile in North America and Europe. This will be followed by a description of the evolutionary dynamics of hipervirulent C. difficile lineages from different parts of the world and the possibility of using vaccines to combat infection due to this organism. The session is important for all physicians and laboratory personal that are involved in health care aspects of patients infected with C. difficile. Upon completion of this Symposium Session the participant should be able to:
- Recognize the differences in antimicrobial resistance and molecular epidemiology of infection due to C. difficile from North American and Europe
- Describe the evolutionary dynamics of hipervirulent and resistant C. difficile lineages from diverse geographic locations
- Examine the role of proteomics as a tool for C. difficile diagnosis
- Examine the possibilities of using vaccines to combat infection due to C. difficile.
$49.99 
 
 
058
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
301
 
This symposium will provide an update on the various methods for diagnosis and performance of susceptibility testing for Mycobacterium tuberculosis. Emphasis will be placed on new molecular platforms that are available or in development for detection of Mycobacterium tuberculosis in clinical samples. There will be a lecture on the performance of interferon gamma release assays with suggestions for their appropriate use. Two presentations will be dedicated to the discussion of challenges and breakthroughs in phenotypic and genotypic susceptibility testing of Mycobacterium tuberculosis.Upon completion of this Symposium Session the participant should be able to:
- Discuss current and emerging platforms for the detection of Mycobacterium tuberculosis in clinical specimens
- Examine the advantages and disadvantages of interferon-gamma release assays
- Discuss the challenges of currently available phenotypic and genotypic susceptibility testing for Mycobacterium tuberculosis.
$49.99 
 
 
059
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
405
 
Antibiotic resistance among gram-negatives is evolving at an ever-increasing rate. Attendees at this symposium will receive current information on the polymyxins as compounds for treatment of multidrug-resistant gram-negative infections. Issues related to pharmacokinetic and pharmacodynamic parameters will be addressed. In vitro susceptibility testing challenges and approaches to interpreting testing results will also be discussed. In addition animal models as tools for better understanding the activities of these antimicrobials will be evaluated. Finally clinical outcome assessments among patients receiving these antimicrobials for treatment of infections caused by multidrug-resistant organisms will be reviewed. Upon completion of this Symposium Session the participant should be able to:
- Develop an approach to educate the end users (clinicians pharmacists and clinical microbiologists) on the impact of PK/PD parameters on the clinical use of the polymyxins
- Examine the various animal models which have been used for evaluating pharmacodynamic parameters for the polymyxins and relevant findings
- Recognize various issues and challenges related to the accurate performance of in vitro susceptibility testing of gram-negative pathogens with the polymyxins
- Explain the rationale for current and proposed in vitro testing interpretive criteria for the polymyxins
- Discuss clinical outcomes data among patients receiving polymyxin class compounds for treatment of infections caused by multidrug-resistant gram-negative pathogens.
$49.99 
 
 
060
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
The quinolone antibiotic class has been one of our most successful weapons in our ongoing battle with bacterial pathogens. These drugs have validated bacterial topoisomerases as important antibacterial targets. In this session we will review the interactions of quinolones with their bacterial targets and explore new chemical compounds that also interact with these DNA replication proteins. It is hoped that new topoisomerase inhibitors can be developed as effective antibacterial agents in the near future. Upon completion of this Symposium Session the participant should be able to:
- Identify how topoisomerase inhibitors kill bacteria
- Gain insights how topoisomerase inhibitors interact with their bacterial targets
- Discuss several new compound classes with the potential for further drug development.
$49.99 
 
 
061
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
503
 
The investigators in this session employ animal models to simulate common pre-natal infections Listeria Salmonella uropathogenic E. coli and toxoplasmosis and to explore the immunologic consequences that determine outcome of pregnancy. Learners interested in understanding how pre-natal infections trigger pregnancy loss and prematurity will want to attend this symposium. Upon completion of this Symposium Session the participant should be able to:
- Discuss the differences among animal models of Listeria Salmonella uropathogenic E. coli and toxoplasmosis
- Identify common mechanisms mediating the consequences of pre-natal infection
- Discuss the functions of Th17 cells and regulatory T-cells.
$49.99 
 
 
062
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
Despite the tremendous success of antiretroviral therapy HIV-infected patients remain at high risk for a number of co-morbidities including cardiovascular diseases and cancers. Multiple studies have suggested a role for persistent immune activation and inflammation in the pathogenesis of these co-morbidities. The relevance of the different biomarkers of immune activation inflammation and senescence needs to be discussed as well as strategies that might modulate the levels of these biomarkers. Upon completion of this Symposium Session the participant should be able to:
- Discuss the relevant biomarkers for assessing persistent immune activation inflammation and senescence in patients with HIV infection
- Discuss the relevance of each of these biomarkers with regards to HIV pathogenesis
- Review current and future strategies that might modulate these different biomarkers and impact on patients outcome.
$49.99 
 
 
063
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Infections of the genitourinary tract are common and the field is challenged by antimicrobial drug resistance. There is a significant need to avoid overtreatment and inappropriate antimicrobial use. This session reviews important concepts in genitourinary tract infections. New information will be presented regarding asymptomatic bacteriuria complications of prostate biopsy/prostatitis and prevention of infection. Upon completion of this Symposium Session the participant should be able to:
- Discuss the importance of identifying asymptomatic bacteriuria
- Recommend strategies for prevention of infections
- Examine the complications of prostate biopsy and multidrug-resistant pathogens
- Recognize the patients who need to be treated for genitourinary tract infection.
$49.99 
 
 
064
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
501
 
In this symposium there will be principles described around the fungal biome at certain host sites and its potential relationship to disease. In this age of powerful tools to understand fungal biology there will be discussion of proteomics and how it impacts the biology and its understanding of molds. We have now performed genomic studies for over a decade on pathogenic fungi so what has it told us and where are we going. Finally how can we use fungal metabolites to help in diagnosis of these difficult-to-treat infections. Upon completion of this Symposium Session the participant should be able to:
- Discuss the principles around the mycobiome
- Examine and review into genomics/proteomic in pathogenic fungi and the principles and potential around them
- Discuss the clinical disease that occurred.
$49.99 
 
 
066
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
207
 
Upon the completion of this Slide Session the participant should be able to:
- Describe role of host immune factors in pathogenesis of C. difficile
- Describe C. difficile virulence factors
- Differentiate impact of antimicrobial agents in producing disease.
$49.99 
 
 
067
Date:
Wednesday, Sep. 11, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
505
 
Upon the completion of this Slide Session the participant should be able to:
- Assess the epidemiology of healthcare workers hand hygiene
- Practices and evaluate recent issues on successful precaution
- Identify new topics in the hand hygiene research agenda
- Review last research innovations in hand hygiene precaution.
$49.99 
 
 
098
Date:
Wednesday, Sep. 11, 2013
 
Time:
1:30 pm –  2:30 pm
 
Track:
Cubist ICAAC Award Lecture
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom 3
 
$49.99 
 
 
099
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
ID Quiz
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 3
 
Participate in the ultimate test of infectious diseases knowledge. Which experts are truly experts? Attendees will improve their general knowledge about infectious diseases microbiology and public health especially in relation to recent developments and emerging infections. Upon completion of the ID Quiz the participant should be able to:
- Discuss topics regarding infectious diseases microbiology virology and public health
- Examine recent and new developments in infectious diseases.
$49.99 
 
 
100
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
This lively interactive case-based session is designed to address controversies and challenges relevant to the management of patients with HIV infection. Presenters will provide challenging cases around patient management including utilizing infection in HIV/HCV coinfection for discussion of clinically-relevant scenarios. Upon completion of this Interactive Symposium the participant should be able to:
- Discuss initiation of antiretroviral therapy
- Discuss the management of patients on antiretroviral therapy
- Describe the management of patients with HIV/HCV coinfection.
$49.99 
 
 
101
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
The session outlined is designed to provide a high-quality evidence-based educational opportunity to advance the competence and understanding of attending physicians trainees and professionals. Through the review and discussion of interesting and relevant cases important information concerning practice performance and methodology is disseminated throughout the field.Cases and multiple choice questions will be presented to the audience for their response; then the answers and the topics will be discussed. Upon completion of this Interactive Symposium Session the participant should be able to:
- Cite some of the latest significant literature of travelers medicine parasitology and tropical medicine
- Examine the epidemiology of travelers illnesses and will understand issues in management and prevention of these illnesses.
$49.99 
 
 
102
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Multidrug-resistant bacteria have greatly influenced the development of new antibacterial agents. Pharmacometric approaches and the use of surrogate markers as primary endpoints are being carefully considered and applied as means to improve the evaluation of new antibacterial agents during drug development programs. This symposium will review the recent evidence regarding organism-specific clinical trials of antibacterial agents and the development of endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. In addition representatives from regulatory agencies will provide a prospective on risk: benefit decisions and applications of pharmacometrics for antibacterial drug development programs. Upon completion of this Symposium Session the participant should be able to:
- Describe the use of pharmacometric solutions for antibiotic development programs
- Evaluate the current recommendations on surrogate markers as primary outcome measures in clinical trials
- Appraise the risk-benefit decisions used in antibacterial drug development programs
- Discuss the applications of pharmacometrics by regulatory agencies of antibacterial agents.
$49.99 
 
 
103
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Genomics is a powerful tool to explore human and pathogen biology in the context of disease mechanisms. These technologies provide a comprehensive analysis of host and/or pathogen genomes. The session will highlight discoveries in human pathogenesis using a variety of genomic approaches. The session will present genome wide association studies pathogen genotyping microbiome studies and whole genome transcriptional analyses to address disease mechanisms. Upon completion of this Symposium Session the participant should be able to:
- Compare the different type of genomic approaches that can be used to study host-pathogen interactions
- Describe how genomic approaches can be used to inform disease models in infectious diseases
- Critically evaluate host and pathogen genomic data
- Recognize pathogen genetic diversity and how this diversity mediates virulence
- Describe how mutations in the host genome can influence patient responses to infection and mediate infection outcomes.
$49.99 
 
 
104
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
That session aims to provide an overview about the mechanisms leading to carbapenem resistance in Gram negatives. The major resistance determinants threatening a large part of the world namely KPC and OXA-48 will be presented in detail. Genetic but also epidemiological aspects will be widely covered. In addition those mostly found in Pseudomonas aeruginosa will be presented and the audience will be able to appreciate to which extent they differ from the former ones. Finally the recent and detailed genetic characterizations of plasmids bearing carbapenemase genes (encoding OXA-48, KPC, NDM...) will be presented. Upon completion of this Symposium Session the participant should be able to:
- Identify molecular mechanisms behind the success of the emerging carbapenemases
- Examine the genetics of the KPC-producing Klebsiella pneumoniae dominant clones
- Recognize genetic features of plasmids disseminating KPC NDM-1 and OXA-48 encoding genes
- Discuss the different epidemiology of producers spreading out and plasmid-mediated carbapenemase interspecific transmission.
$49.99 
 
 
105
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
This session will provide an overview on present areas of interest in sepsis. It will include two topics about cutting-edge research areas on pathogenic aspects (such as implications of endothelial activation and dysfunction and dendritic and myeloid-derived suppressor cells). Also 2 areas of immediate interest for clinical application will be covered: novel tools for rapid diagnostics of sepsis which is a critical aspect for the outcome of patients and combination therapy a highly controversial topic that will be addressed from the perspective of evidence-based medicine. Upon completion of this Symposium Session the participant should be able to:
- Discuss the role of endothelial activation and dysfunction and dendritic and myeloid-derived suppressor cells in the pathogenesis of sepsis and their implications for potential innovative therapeutic approaches
- Recommend the best novel tools for early diagnosis of sepsis and know their limitations and advantages
- Identify whether combined antimicrobial therapy is to be used in patients with sepsis or under which circumstances.
$49.99 
 
 
106
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
In this session up-to-date CLSI and EUCAST recommendations and guidelines regarding antimicrobial susceptibility testing will be presented. There will also be special focus on antimicrobial susceptibility testing of hepatitis C virus and Candida species. Challenges controversies and the current state-of-the-art will be addressed. Upon completion of this Symposium Session the participant should be able to:
- Review current CLSI and EUCAST guidelines regarding antimicrobial susceptibility testing
- Assess what clinicians should know about and when to request antimicrobial susceptibility testing for clinical care
- Review unsettled issues and pitfalls of current antimicrobial susceptibility testing methods and their clinical application.
$49.99 
 
 
107
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
503
 
Bacterial biofilms are a major clinical challenge and inherently resistant to antimicrobials this session will examine a number of novel approaches to treat or prevent biofilm infections. Speakers will present data regarding new methods to study biofilms as well as strategies to destroy and inhibit biofilm formation. Upon completion of this Symposium Session the participant should be able to:
- Discuss the role of biofilms in infection
- Discuss the structure and formation of biofilms
- Analyze novel approaches being developed to inhibit or destroy biofilms
- Discuss different methods used for the study of biofilms
$49.99 
 
 
108
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
405
 
β-lactamase-mediated resistance to β-lactams such as cephalosporins and carbapenems is increasing among the gram-negative bacteria and is of growing concern. The combination of β-lactamase-labile penicillins (for example amoxillin or piperacillin) with a specific β-lactamase inhibitor has proven to be an effective strategy for contering this threat. The session will review new β-lactamase inhibitors hold the promise to encompass the emerging carbapenemases that pose a severe threat the carbapenems and thus restore the activity of these agents against gram-negative bacteria. Upon completion of this Symposium Session the participant should be able to:
- Discuss the problems associated with β-lactamase-mediated resistance
- Examine mechanism-based inhibitors of β-lactamases
- Discuss insights into the development of new combinations of β-lactams and β-lactamase inhibitors.
$49.99 
 
 
109
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
505
 
In this session experts will present state-of-the-art advances in pediatric infectious diseases in lecture format. Time will be available after each presentation for questions from attendees and additional discussion. Upon completion of this Symposium Session the participant should be able to:
- Discuss contemporary advances in pathogenesis diagnosis and treatment of key pediatric infectious diseases and their importance to child health
- Summarize the potential impact of implementation of scientific advances to improve child health
- Apply updated information to communication decision-making and clinical practice.
$49.99 
 
 
110
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
501
 
The disruption of the human microbiome through use of antimicrobials is a topic of growing interest among healthcare epidemiologists not only because perturbation of the microbiome is the major risk factor for Clostridium difficile infection (CDI) but also because it could be a driving force behind the introduction and proliferation of multidrug-resistant organsms (MDROs) in healthcare settings. A greater understanding of the protective role of the microbiome could have major implications for the future direction of infection control. The speakers will review the current understanding of the role of microbiome disruption in the epidemiology of diseases such as CDI and MDRO colonization and transmission and what the future may hold with regard to intervention. Upon completion of this Symposium Session the participant should be able to:
- Discuss the relationship between antimicrobial use and disruption of the human microbiome
- Review the rationale for and data supporting use of fecal transplantation in treatment and prevention of Clostridium difficile infection
- Discuss the potential role of probiotics in preserving or restoring a disrupted microbiome
- Discuss CDI in pediatric populations.
$49.99 
 
 
111
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
Infectious disease physicians and microbiologists frequently manage infections in patients with underlying disorders that do not fall into classical transplant immunosuppression or acquired immunodeficiency categories. This session will provide fresh insight into single gene disorders that predispose to infection and enable infection specialist to identify and manage such patients more effectively. The pathophysiology of such disorders and the consequent infections will be of interest to both clinical and non-clinical attendees. Many patients within haematological practice are hyposplenic either through splenectomy or functional hyposplenism; ID physicians and microbiologists should be aware of the specific immune defects that may arise and guidance that is available regarding monitoring of such patients and prophylaxis. Upon completion of this Symposium Session the participant should be able to:
- Examine and recognize infection linked to single gene defects in transcription factors
- Describe infections linked to genetic defects in haemoglobin
- Review the immunological defects and infection risks linked to splenectomy and practice recommendations.
$49.99 
 
 
112
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
301
 
Upon the completion of this Slide Session the participant should be able to:
- Apply data on the occurrence and dissemination of clinically significant anti-microbial marker among gram-positive cocci
- Report updated information on the evolution of antimicrobial resistance and molecular characterization among staphylococci
- Examine data on the impact of pneumococcal vaccines on the emergence of non-vaccine S. pneumonia serotypes and on the evolutions of antimicrobial resistance.
$49.99 
 
 
113
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
Upon the completion of this Slide Session the participant should be able to:
- Describe mechanisms on decreasing resistance in developing world
- Describe the prevalence on antimicrobial resistance in developing world
- Describe mechanisms of resistance in returning travelers.
$49.99 
 
 
114
Date:
Wednesday, Sep. 11, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
207
 
Upon the completion of this Slide Session the participant should be able to:
- Recognize patters of infection in hematopoietic stem cell recipient
- Discuss the impact of bacterial infections on outcomes in transplantation
- Analyze geographically restricted infection patterns in transplantation.
$49.99 
 
 
115
Date:
Wednesday, Sep. 11, 2013
 
Time:
5:45 pm –  7:15 pm
 
Track:
Special Interest Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
$49.99 
 
 
116
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
β-lactamases are the major cause of resistance to β-lactam antibiotics. Since the discovery of penicillin bacteria have evolved to produce β-lactamases capable of inactivating each new class of β-lactam antibiotics. Every year there are a plethora of publications regarding β-lactamases and cover a variety of subjects including epidemiology genetic and biochemical characterizations structural elucidation and clinical impact. Ten interesting and impactful publications from the literature in 2013 will be chosen and discussed by the team of experts. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Identify current literature in β-lactamases
- Discuss novel findings in current publications
- Examine the impact of new research.
$49.99 
 
 
117
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
301
 
Increased incidence of antibiotic resistance has eroded the effectiveness of these valuable drugs. Combined with the decline of R&D in the large pharmaceutical companies over the past 10-15 years few new antibiotics have reached the market in recent times. Regulatory guidelines particularly in the US have also contributed to reduced development candidates. This session will discuss these issues and explore potential solutions to improve the antibiotic pipeline. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the problems confronting antibiotic development today
- Identify initiatives to facilitate antibiotic development
- Examine insights into the development of new drugs for today's needs.
$49.99 
 
 
118
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
203
 
The optimal use of antiretroviral therapy for the prevention of mother to child transmission has dramatically changed the risk of HIV-1 transmission to infants in the developed and developing world. In the developed world transmission from mother to child should be uncommon but there are still infants at risk due to late presentation to care HIV-1 resistance to antiretrovirals and adherence/tolerability of medications. In the developing world recent studies have shown that maternal treatment with combination therapy may be the most effective intervention but implementation may be challenging. Two world experts will provide their guidance on these issues. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Review current practice guidelines on the use of antiretroviral agents for prevention of mother to child transmission in the developed world
- Review recent data on prevention of mother to child transmission in the developing world
- Discuss potential clinical and logistical issues that prevent optimal use of antiretroviral therapy for PMTCT
- Examine the logistical hurdles of reaching the goals of zero MTCT in the next decade.
$49.99 
 
 
119
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
The speakers will identify and discuss important infection and prevention publications from the past year. This review will give attendees an overview of the most significant findings in this field and will put the findings in perspective. Attendees are likely to learn about papers that they have not encountered on their own and will be challenged to evaluate practices at their healthcare facilities. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Identify several of the most significant publications in infection prevention in the past year
- Discuss the important findings of at least one of these publications
- Identify at least one infection prevention and control issue that their healthcare facility should address in the next year.
$49.99 
 
 
120
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
112
 
The session will bring together an ENT surgeon with an infection/microbiology specialist to talk through how they manage some of the clinical scenarios that infection specialists find most challenging including for example chronic rhinosinusitis (bacterial/fungal) and malignant otitis. While there are guidelines published for common ENT conditions such as acute sinusitis there are no guidelines for the more infrequent but lethal conditions. The session aims to provide some practical solutions for difficult clinical cases. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Evaluate and apply accepted management guidelines for serious ENT infections
- Determine the most practical and effective management plans for rhinosinusitis
- Examine the patients who will require combined medical and surgical therapy.
$49.99 
 
 
121
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
505
 
Sexually transmitted infections (STIs) are a major threat to reproductive health. The field is challenged by the emergence of drug-resistant pathogens and the presence of HIV in association with other STIs. In addition the diagnostic approach to STIs is changing as more molecular and rapid tests are coming into clinical practice. This session will provide an interactive forum for attendees to ask leading experts about the diagnosis management and epidemiology of STIs. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the important STIs affecting patients around the world
- Recommend strategies for diagnosing STIs
- Examine the evidence base for our current approaches to STI management
- Recognize the latest developments in STI epidemiology diagnosis and treatment.
$49.99 
 
 
122
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
405
 
In this discussion the experts will use both their experience with cryptococcosis in AIDS patients and those with non-AIDS cryptococcosis. There will be discussion of diagnosis pathogenesis and treatment of this deadly and common disease. Furthermore these experts will be able to discuss both cryptococcal species (C. gattii and C. neoformans) and their impact on the immune system.Upon completion of this Meet-the-Experts Session the participant should be able to:
- Discuss the Immune Reconstitution Inflammatory Syndrome
- Discuss issues around management of cryptococosis
- Provide the framework for understanding C. neoformans and C. gattii infections.
$49.99 
 
 
123
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
401
 
After brief introductory state-of-the-art lectures on two primary reasons for treatment failure i.g. fungal resistance and host genetic susceptibility the experts and the audience will engage in a discussion on how to deal with these two and other obstacles in managing invasive fungal infection. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Debate reasons for failure of antifungal treatment
- Classify antifungal drugs by their potential to fail
- Integrate fungal resistance and host genetics into clinical decision making processes.
$49.99 
 
 
124
Date:
Thursday, Sep. 12, 2013
 
Time:
7:00 am –  8:15 am
 
Track:
Meet-the-Experts
 
Recording Type:
Synchronized
 
Room:
205
 
This meet-the-expert session will focus on infection control issues that are relevant to transplant recipients. The impact of antimicrobial stewardship on hospital-acquired infections including with multi drug resistant pathogens will be discussed. Infection control issues pertaining to respiratory virus infections a significant cause of hospital acquired infections on transplant units will also be reviewed. Upon completion of this Meet-the-Experts Session the participant should be able to:
- Recognize the impact of antimicrobial selection on hospital acquired infections in transplant recipients
- Discuss how infection control measures may affect the spread of respiratory viruses on transplant units
- Review important infection control issues related to transplant recipients.
$49.99 
 
 
126
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
Antimicrobial resistance is an urgent public health problem. New ways to prevent the emergence of drug resistance and treat it when present are required. This symposium will address the use of combination antimicrobial chemotherapy for the prevention and management of drug resistance for a range of microbial pathogens. Upon completion of this Interactive Symposium Session the participant should be able to:
- Identify the use of combination chemotherapy for the prevention and treatment of antimicrobial resistance
- Recognize the pros and cons of using combinations of antimicrobial agents as a strategy for combating resistance
- Discuss the limitations of current knowledge and areas for future research.
$49.99 
 
 
127
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
Pneumonia is a major cause of morbidity and mortality. This session provides an update on causative pathogens associated with community-acquired pneumonia. It also reviews the latest information regarding pneumonia in special populations such as older adults and people living in resource-poor settings. The prevention of pneumonia through vaccination of adults and other measures will also be updated. International experts in the field will deliver these talks to ensure the most important and cutting edge information is provided. Upon completion of this Interactive Symposium Session the participant should be able to:
- Discuss the important microbial pathogens implicated in community-acquired pneumonia (CAP)
- Recommend strategies in adults to prevent CAP
- Examine the causes of CAP in resource poor settings and older adults
- Recognize the impact of molecular techniques in understanding the causes of pneumonia.
$49.99 
 
 
128
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
503
 
Community-acquired invasive infections due to S. aureus have increased significantly in recent years. This session will examine the underlying mechanisms for the emergence of highly invasive disease including persistent bacteremia. It will also address possible human genetic factors that affect the course of infection. Finally we will examine the prospects for developing a vaccine against S. aureus. Upon completion of this Symposium Session the participant should be able to:
- Distinguish the role of virulence factors such as toxins in the pathogenesis of invasive S. aureus infection
- Differentiate the key clinical features of sustained bacteremia due to USA300 and related isolated from infection due to other strains
- Discuss some novel strategies for vaccine development and what sets them apart from prior unsuccessful approaches
- Explain how genetic differences may lead to enhanced susceptibility to S. aureus disease.
$49.99 
 
 
130
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
113
 
The cell wall is one of the most unique features of bacterial pathogens. From the discovery of penicillin the machinery involved in cell wall synthesis has been exploited for antimicrobial therapy. This symposium on the bacterial cell wall will provide an overview of this important antibacterial drug target. The genes and the machinery involved in constructing the cell wall and cell division will be explored. Upon completion of this Symposium Session the participant should be able to:
- Identify the basic component of the bacterial cell wall
- Discuss the function genes involved in cell wall assembly and cell division
- Identify potential drug targets in this pathway.
$49.99 
 
 
131
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
301
 
This session will provide an overview on the latest developments in clinical aspects of carbapenemase-producing bacteria. The session will start with an introduction to the different carbapenemases (i.e. VIMs IMPs NDMs KPCs OXAs). This will be followed by lectures summarizing the latest data on the molecular epidemiology laboratory detection and treatment issues of bacteria that produce these types of carbapenemases. The session is important for all physicians and laboratory personal that are involved in health care aspects of patients infected with bacteria that produce carbapenemases. Upon completion of this Symposium Session the participant should be able to:
- Discuss the clinical importance of bacteria that produce carbapenemases
- Recognize the changing epidemiology of bacteria that produce carbapenemases
- Identify how to approach the laboratory detection and screening of bacteria that produce carbapenemases
- Recommend which treatment options are available for infections due to bacteria that produce carbapenemases.
$49.99 
 
 
132
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
405
 
Matrix assisted laser desorption ionization time of flight (MALDI-ToF) mass spectrometry (MS) is increasingly used in clinical microbiology laboratories for bacterial and fungal identification. Newer applications such as strain typing and antimicrobial susceptibility testing are evolving. This session delivered by experienced users of the technology will be a state-of-the-art presentation on this technology and its clinical application(s). Upon completion of this Symposium Session the participant should be able to:
- Review MALDI-ToF MS for bacterial and fungal identification
- Assess what clinicians should know about MALDI-ToF MS and how it is utilized in clinical microbiology
- Review unsettled issues and pitfalls of current MALDI-ToF MS methods and their clinical application.
$49.99 
 
 
133
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
The outer membrane of gram-negative bacteria presents a formidable barrier to the free access of the majority antibiotics to their cellular targets. Bacteria maintain transport systems in the outer membrane that constitute the principal route by which antibiotics enter the cell and efflux systems that serve to limit entry by actively pumping the compounds out again. Resistance can be achieved through decreasing the activity of the uptake path or through increasing the efflux path. The session will review recent highlights in the understanding of how these transport and efflux systems contribute to the activity of antibiotics. Upon completion of this Symposium Session the participant should be able to:
- Discuss the translocation of antibiotics across the gram-negative bacteria
- Identify the role of transport systems in bacterial resistance
- Examine the development of new drugs that can better exploit translocation routes.
$49.99 
 
 
134
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
Antiretroviral therapy continues to evolve with several new combination first line therapies now available allowing for further individualization of therapy. Multiple potential treatment regimens for first line failures are possible but data are limited and choices in resource rich and resource limited setting may be different. Expert insight into decision making is critical. Finally an update on the pipeline on new antiretroviral will be provided. Are the new options for the future or has the flow in the pipeline become a trickle? Upon completion of this Symposium Session the participant should be able to:
- Discuss choices for initial antiretroviral therapy of HIV-1 infection and understand the advantages and disadvantages of preferred regimens
- Discuss options for second line therapy in patients who have virologic failure on first line therapy. Understand how these options may differ depending on treatment setting
- Review new drugs in the HIV-1 treatment pipeline and how they may be used when they become available.
$49.99 
 
 
135
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
This session provides an overview of the problem of multidrug-resistant gram-negative bacterial infections including proposals for future key studies surveillance issues and the associated economic burden. Infections due to MDR gram-negative bacteria such as ESBL or carbapenemase-producing Enterobacteriaceae and A. baumannii or P. aeruginosa are a serious problem in the hospital setting. Most health professionals are seeing rising numbers of these and face increasingly difficult challenges to define appropriate treatment and prevent transmission.Upon completion of this Symposium Session the participant should be able to:
- Examine the profile of resistance to currently used antimicrobial agents
- Identify current controversies in antimicrobial resistance
- Analyze an overview on the global epidemiology of multidrug-resistant gram-negatives and associated costs
- Describe how future academic research could progress to gain greater insight into transmission control strategies.
$49.99 
 
 
136
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
401
 
This symposium will focus on new developments in the diagnosis and management of herpesvirus infections. Specifically the impact of the new international standard for CMV and the interpretation of low viral loads will be discussed. The results of the 2012 CMV consensus conference will be reviewed. New therapeutics including immune based therapies and novel antivirals will be presented. Upon completion of this Symposium Session the participant should be able to:
- Discuss the impact of the new international standards on CMV diagnosis
- Recognize different options for prevention and treatment of CMV based on international consensus guidelines
- Evaluate treatment options for herpes viruses.
$49.99 
 
 
137
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 10:30 am
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom 3
 
Chronic hepatitis C is a complex disease for which new treatments are available but potentially associated with serious adverse events. The goal is to review and carefully assess the role of new therapeutic options. Upon completion of this Symposium Session the participant should be able to:
- Describe the role of new anti-HCV drugs
- Identify treatment strategy risk side effects and benefits
- Discuss the role of laboratory tools used to monitor HCV
- Identify how to prevent HCV complications in HIV infected patients.
$49.99 
 
 
138
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
501
 
Upon the completion of this Slide Session the participant should be able to:
- Assemble gut microbiota in ELBW infants
- Idenitfy vancomycin pharmacokinetics and resistance
- Discuss epidemiology of meningococcal carriage and infection
- Examine epidemiology of group A streptococus colonization and pharyngitis
- Identify diagnostic conflicts in VAP.
$49.99 
 
 
139
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Upon the completion of this Slide Session the participant should be able to:
- List 3 risk factors for surgical site infections
- Describe one novel approach to diagnosis of prosthetic joint infections
- List one novel approach to prevention of surgical site infections
- Describe one novel option for treatment of prosthetic joint infections
$49.99 
 
 
140
Date:
Thursday, Sep. 12, 2013
 
Time:
8:30 am – 11:00 am
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
Upon the completion of this Slide Session the participant should be able to:
- Assess study the epidemiology of severe infection in neutropenic and hemato-oncology patients
- Assess prevention and control measures for the prevention of bloodstream infection among neutropenic patients
- Determine infection control in high-risk patients.
$49.99 
 
 
170
Speaker:
 
Date:
Thursday, Sep. 12, 2013
 
Time:
1:30 pm –  2:30 pm
 
Track:
Special Address
 
Recording Type:
Live Stream
 
Room:
Mile High Ballroom 3
 
Dr. Trevor Mundel, renowned scientist and President of Global Health-Program at the Gates Foundation, will discuss the vision for global health and infectious diseases from the foundation's perspective. Dr. Mundel will address current vaccine discovery programs, strategies for the future, neglected diseases and plans for accelerating research and development efforts for low resource settings through new partnerships and programs.

$49.99 
 
 
171
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 1
 
The conveners will present a selection of challenging cases in pediatric infectious diseases. Conveners will solicit discussion from panelists as to differential diagnosis and approach to evaluation and management. Questions will be posed in the audience response format so that attendees can weigh-in as a measure of their personal diagnostic and therapeutic acumen. Conveners will prepare a brief summary of the important teaching points for each case presented. Upon completion of this Interactive Symposium Session the participant should be able to:
- Identify some common and not-so-common clinical manifestations of important infectious diseases in childhood
- Identify medical evidence and current expert opinion in management and prevention of infections in childhood
- Assess and compare knowledge anonymously with peers
- Recognize and identify unusual infectious diseases.
$49.99 
 
 
172
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Interactive Symposium
 
Recording Type:
Synchronized
 
Room:
Mile High Ballroom 4
 
This session will address several controversial topics in infection prevention. The question of whether hand hygiene is the most important infection prevention activity will be addressed through a debate. The question of whether antimicrobial coatings on surfaces or fabrics are an important infection prevention measure will be addressed through a literature review. The question of whether no touch disinfection methods (e.g. UV light hydrogen peroxide vapor) are important infection prevention measures will be addressed through a literature review. Upon completion of this Interactive Symposium Session the participant should be able to:
- Discuss the evidence for and against hand hygiene being the most important infection prevention measure
- Discuss the evidence for and against antimicrobial coatings as an infection prevention measure
- Discuss the evidence for and against no touch disinfection methods (e.g. UV light hydrogen peroxide vapor) as an infection prevention measure.
$49.99 
 
 
173
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 1
 
Alternative strategies for administering anti-infective agents are increasingly being used to improve anti-infective pharmacotherapy. In addition alternative dosing and administration strategies of several new anti-infective agents are actively being pursued in drug development programs. This symposium is aimed at providing clinicians and researchers with the latest developments on alternative techniques for administering anti-infective agents discuss the pharmacokinetic/pharmacodynamic considerations of these dosing strategies and illustrate current applications for the treatment of clinical infection diseases. Upon completion of this Symposium Session the participant should be able to:
- Evaluate the role of intraventricular administration of vancomycin for central nervous system infections
- Describe the pharmacokinetic/pharmacodynamic issues associated with aerosol delivery of antibiotics
- Appraise the use of extended infusions of beta-lactam agents in various patient populations
- Propose an individualized dosing method for anti-infective agents with a narrow therapeutic index.
$49.99 
 
 
174
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
203
 
There are still many unanswered questions in regard to the details of bacterial death particularly upon exposure to certain antibiotics. This is particularly true of the fluoroquinolone class. Also not all members of a bacterial population are necessarily killed as so-called persisters can survive and prolong infections. A better understanding of these processes could assist in the identification of new classes of antibacterial drugs. Upon completion of this Symposium Session the participant should be able to:
- Distinguish bacterial cell death upon antibiotic exposure
- Differentiate molecular biochemical and cellular events that occur as bacteria are killed
- Examine bacterial persisters and their role in bacterial infections.
$49.99 
 
 
175
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
501
 
Upon completion of this Symposium Session the participant should be able to:
- Discuss the cardinal and distinguishing clinical symptoms and signs of infections presenting in developing countries
- Examine empirical management of fever meningitis or encephalitis
- Identify the role of combination therapy in cysticercosis and echinococcosis.
$49.99 
 
 
176
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
112
 
Infections that complicate pregnancy and delivery are important causes of maternal and child morbidity and mortality. This session focuses on major infectious disease threats in pregnant and postpartum women. Attendees of this symposium will gain new knowledge about chorioamnionitis malaria during pregnancy puerperal sepsis and infections that complicate unsafe abortion. Upon completion of this Symposium Session the participant should be able to:
- Discuss the important consequences of chorioamnionitis
- Recommend strategies for recognizing infectious diseases that complicate pregnancy
- Examine the features and consequences of malaria during pregnancy
- Recognize the infections that complicate unsafe abortion.
$49.99 
 
 
177
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
301
 
This is a critical analysis of what the faculty of this symposium considers the most interesting and exciting published papers in mycology over the year. These papers can range from basic to the clinical arena with a primary emphasis on the discussion of fungal diseases and their epidemiology diagnosis and treatment. It is hoped that authors of manuscripts will be in the audience to provide a lively discussion. Upon completion of this Symposium Session the participant should be able to:
- Discuss principles in fungal pathogenesis diagnosis treatment and epidemiology
- Identify the strengths and weaknesses of specific fungal related manuscripts
- Focus on the important issues of clinical mycology today.
$49.99 
 
 
178
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
401
 
Recent award recipients from the developing and developed world will describe their winning proposals and their potential impact. Upon completion of this Symposium Session the participant should be able to:
- Cite the award winning proposals and the paths taken to successfully develop a funded academic career in global health research
- Discuss the Rising Stars program and the role of new funding opportunities for trainees in infectious diseases and global health.
$49.99 
 
 
179
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:00 pm
 
Track:
Symposium
 
Recording Type:
Synchronized
 
Room:
205
 
This symposium will review key infections that may affect outcomes after solid organ and hematopoetic stem cell transplant including Burkholderia cepacia Aspergillus Hepatitis C and Tuberculosis. Contraindications to transplantation will be outlined. Prophylactic interventions will be discussed and post-transplant management strategies reviewed. After this symposium the attendee will have a better understanding of how to manage patients with these infections which have often been considered to be relative or absolute contraindications to transplantation. Upon completion of this Symposium Session the participant should be able to:
- Recognize infections that may present unique challenges to transplantation
- Discuss when pre transplant infections are absolute contraindications to transplantation
- Evaluate prophylactic measures for transplant candidates with difficult to treat infections.
$49.99 
 
 
180
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 4
 
Upon the completion of this Slide Session the participant should be able to:
- Describe the effects of drugs on immune response to infection
- Examine the effects of immune factors on pathogenetics of infection
- Describe role of host genetic factors on pathogenetics of infection.
$49.99 
 
 
181
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
405
 
Upon the completion of this Slide Session the participant should be able to:
- Locate the role of efflux in bacterial resistance
- Examine the interplay of outer membrane proteins in bacterial cell penetration
- Discover the range of antibiotics affected by efflux.
$49.99 
 
 
182
Date:
Thursday, Sep. 12, 2013
 
Time:
3:00 pm –  5:30 pm
 
Track:
Slide Session
 
Recording Type:
Synchronized
 
Room:
Four Seasons Ballroom 3
 
Upon the completion of this Slide Session the participant should be able to:
- Apply an over view of molecular epidemiology of carbapenemases
- Distinguish new data about the complexity in the epidemiology of microorganisms harboring these enzymes
- Formulate information that would be useful to design infection control activities.
$49.99 
 
 
 
1 - 100 of 124
Order By 
Show 
Last Page
Page 
Next Page
 
ICAACOnline.com © 2014 Digitell, Inc.         Home         Sign In         Cart         Contact Us